|
II. Prohibited Methods
II.A. Enhancement of oxygen transfer
a) Blood doping: Blood
doping is the administration of autologous, homologous or heterologous blood
or red blood cell products of any origin, other than for legitimate medical
treatment.
b) Other Products: The
administration of products that enhance the uptake, transport or delivery of
oxygen, e.g. modified haemoglobin products including but not limited to bovine
and cross-linked haemoglobins, microencapsulated haemoglobin products,
perfluorochemicals, and RSR13 (Efaproxiral).
II.B. Pharmacological, chemical
and physical manipulation
Pharmacological, chemical and
physical manipulation is the use of substances and methods, including masking
agents (ref I.G.), which alter, attempt to alter or may reasonably be expected
to alter the integrity and validity of specimens collected in doping controls.
These include, without limitation, catheterisation, urine substitution and/or
tampering, inhibition of renal excretion and alterations of testosterone and
epitestosterone (ref I.G.) measurements.
Note: The
success or failure after using a prohibited substance is irrelevant. Relevant
for sanctions is the use or intended use of a prohibited substance or method.
II.C. Gene doping
Gene or cell doping is defined as
the non-therapeutic use of genes, genetic elements and/or cells that have the
capacity to enhance athletic performance.
| 
